Inductive Bio

Decision/Risk Analysis · New York, NY · Founded 2021 · Privately Held (backing)

Developer of a machine learning platform designed to accelerate the compound optimization process. Inductive Bio is based in New York, NY and was founded in 2021. It was valued at $80 million at its early-stage round in May 2025, the last priced event on record. It has raised $29.4 million across 2 recorded rounds; the latest was a $25.1 million early-stage round in Mar 2025.

PMV mark · valuation
$80.0M
Oct 2026
Priced at
its early-stage round
May 2025
Total raised
$29.4M
Last round
Early Stage VC
Mar 2025
What is Inductive Bio worth?
$80.0MPrivateMarketView mark · Oct 2026

Valued at $80.0M at its early-stage round, May 2025. Nothing has traded since.

Free account
More of Inductive Bio with a free account
  • ·The complete investor list: 16 names
  • ·Watch Inductive Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Inductive Bio funding history

2 rounds
DateRoundRaisedPost-money
Mar 2025Early Stage VC$25.1M▮
Dec 2023Seed Round$4.3M▮
Unlock post-money valuations

Membership and data by Private Market View

Inductive Bio valuation

Inductive Bio was valued at $80 million at its early-stage round in May 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Inductive Bio raised?

Inductive Bio has raised $29.4 million across 2 recorded rounds since 2023. The largest was a $4.3 million seed round in Dec 2023; the most recent was a $25.1 million early-stage round in Mar 2025.

Inductive Bio has filed 1 Form D with the SEC, most recently in May 2025 ($25.1 million sold to 10 investors).

Comparable companies

Comparable decision/risk analysis names by valuation on PrivateMarketView: Anumana ($580 million), VideaHealth ($400 million) and Cellens ($19.4 million).

How Inductive Bio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Inductive Bio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Inductive Bio

What is Inductive Bio worth?
Inductive Bio is valued at $80.0M as of Oct 2026. Valued at $80.0M at its early-stage round, May 2025. Nothing has traded since.
How much has Inductive Bio raised?
Inductive Bio has raised $29.4M in total funding across 2 recorded rounds.
When did Inductive Bio last raise?
Inductive Bio last raised in Mar 2025 (Early Stage VC), raising $25.1M.